Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTKB | AMGN | VRTX | REGN | GILD |
| Company | Cytek Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.59 | 311.03 | 472.14 | 1,027.47 | 66.62 |
| High | 5.60 | 313.41 | 476.57 | 1,040.05 | 66.93 |
| Low | 5.44 | 308.57 | 471.76 | 1,025.80 | 66.01 |
| Last | 5.60 | 310.88 | 474.57 | 1,034.23 | 66.69 |
| Change | +0.03 | +1.50 | +4.29 | +10.14 | +0.10 |
| % Change | +0.54% | +0.48% | +0.91% | +0.99% | +0.15% |
| Volume | 225,894 | 1,189,412 | 778,665 | 411,324 | 4,096,405 |
| 20-Day Average Volume | 837,411 | 2,339,178 | 1,228,461 | 470,109 | 9,040,718 |
| Previous Close | 5.57 | 309.38 | 470.28 | 1,024.09 | 66.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.72 | 308.00 | 475.19 | 1,037.75 | 66.78 |
| 20-Day Raw Stochastic | 25.34% | 50.03% | 48.33% | 47.32% | 42.18% |
| 20-Day Relative Strength | 44.88% | 55.59% | 60.06% | 56.51% | 49.00% |
| Weighted Alpha | -33.59 | +36.32 | +41.99 | +45.33 | -13.52 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Last Month's Opinion | 88% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.64% since 06/27/24 | -0.95% since 06/27/24 | +0.41% since 06/27/24 | -1.57% since 06/27/24 | -3.11% since 06/27/24 |
| Low | 5.44 on 07/05/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 5.78 on 07/03/24 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,069.69 on 07/01/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -2.62% since 06/05/24 | +1.09% since 06/05/24 | -1.78% since 06/05/24 | +2.83% since 06/05/24 | +4.40% since 06/05/24 |
| Low | 5.26 on 06/27/24 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 992.22 on 06/10/24 | 62.69 on 06/18/24 |
| High | 6.52 on 06/12/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -14.68% since 04/05/24 | +15.10% since 04/05/24 | +16.66% since 04/05/24 | +9.72% since 04/05/24 | -4.15% since 04/05/24 |
| Low | 5.26 on 06/27/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 7.02 on 04/09/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -30.86% since 01/05/24 | +2.55% since 01/05/24 | +13.91% since 01/05/24 | +13.27% since 01/05/24 | -19.95% since 01/05/24 |
| Low | 5.26 on 06/27/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 9.33 on 03/04/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 731,191 | 165,962,256 | 121,357,168 | 112,840,368 | 82,961,352 |
| Shares Outstanding, K | 131,273 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 193,020,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -12,150,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 44,860,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -6,170,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.33 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/13/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.68 | 31.46 | 28.15 | 16.97 |